Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
Date:8/6/2008

3,475,157 3,059,301

Intangible assets 2,936,388 2,978,706

Goodwill 3,589,879 3,855,971

Other non-current assets 1,501,538 1,459,198

Total assets $11,502,962 $11,353,176

Liabilities

Current liabilities $2,106,648 $2,002,351

Long-term debt 4,728,854 4,706,716

Other non-current liabilities 1,506,282 1,206,358

Total liabilities 8,341,784 7,915,425

Minority interest 31,624 34,325

Total shareholders' equity 3,129,554 3,403,426

Total liabilities and shareholders'

equity $11,502,962 $11,353,176


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email: